Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Healthcare Institute, Boston, MA 02215, USA.
Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA.
Sci Transl Med. 2020 Nov 4;12(568). doi: 10.1126/scitranslmed.aay5067.
Antibiotic resistance is a major cause of treatment failure and leads to increased use of broad-spectrum agents, which begets further resistance. This vicious cycle is epitomized by uncomplicated urinary tract infection (UTI), which affects one in two women during their life and is associated with increasing antibiotic resistance and high rates of prescription for broad-spectrum second-line agents. To address this, we developed machine learning models to predict antibiotic susceptibility using electronic health record data and built a decision algorithm for recommending the narrowest possible antibiotic to which a specimen is susceptible. When applied to a test cohort of 3629 patients presenting between 2014 and 2016, the algorithm achieved a 67% reduction in the use of second-line antibiotics relative to clinicians. At the same time, it reduced inappropriate antibiotic therapy, defined as the choice of a treatment to which a specimen is resistant, by 18% relative to clinicians. For specimens where clinicians chose a second-line drug but the algorithm chose a first-line drug, 92% (1066 of 1157) of decisions ended up being susceptible to the first-line drug. When clinicians chose an inappropriate first-line drug, the algorithm chose an appropriate first-line drug 47% (183 of 392) of the time. Our machine learning decision algorithm provides antibiotic stewardship for a common infectious syndrome by maximizing reductions in broad-spectrum antibiotic use while maintaining optimal treatment outcomes. Further work is necessary to improve generalizability by training models in more diverse populations.
抗生素耐药性是治疗失败的主要原因,导致广谱药物的使用增加,进而产生更多的耐药性。这种恶性循环以简单的尿路感染 (UTI) 为代表,一生中每两个女性中就有一个会受到影响,并且与抗生素耐药性的增加和广谱二线药物的高处方率有关。为了解决这个问题,我们开发了使用电子健康记录数据预测抗生素敏感性的机器学习模型,并构建了一种决策算法,以推荐对标本最敏感的最窄谱抗生素。当将该算法应用于 2014 年至 2016 年期间就诊的 3629 名患者的测试队列时,与临床医生相比,该算法将二线抗生素的使用减少了 67%。与此同时,与临床医生相比,它将不适当的抗生素治疗(即选择对标本耐药的治疗方法)减少了 18%。对于临床医生选择二线药物而算法选择一线药物的标本,92%(1066/1157)的决策最终对一线药物敏感。当临床医生选择不适当的一线药物时,算法选择适当的一线药物的概率为 47%(183/392)。我们的机器学习决策算法通过最大限度地减少广谱抗生素的使用,同时保持最佳治疗效果,为常见感染综合征提供了抗生素管理。通过在更多样化的人群中训练模型,进一步提高泛化能力是必要的。